Skip to main content
Allan Gibofsky, MD, Rheumatology, New York, NY

AllanGibofskyMD

Rheumatology New York, NY

Professor of Medicine, Cornell University-Weill Medical College

Dr. Gibofsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gibofsky's full profile

Already have an account?

  • Office

    535 E 70th St
    New York, NY 10021
    Phone+1 212-606-1423
    Fax+1 212-628-0354

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1974 - 1979
  • New York Presbyterian Hospital
    New York Presbyterian HospitalInternship, Transitional Year, 1973 - 1974
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1973

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1974 - Present
  • NY State Medical License
    NY State Medical License 1974 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Master (MACR) American College of Rheumatology
  • Top Doctors: New York Metro Area Castle Connolly, 2005-2014

Publications & Presentations

PubMed

Other

Press Mentions

  • Provider and Patient Knowledge Gaps on Biosimilars: Insights from Surveys
    Provider and Patient Knowledge Gaps on Biosimilars: Insights from SurveysNovember 1st, 2022
  • RA Awareness Day 2021: Rheumatologists Show Support, Provide Guidance for Patients
    RA Awareness Day 2021: Rheumatologists Show Support, Provide Guidance for PatientsFebruary 2nd, 2021
  • MDNN: Pediatric HIV, Diabetes Websites, Hypertension Guidelines, and an FDA Drug Tablet
    MDNN: Pediatric HIV, Diabetes Websites, Hypertension Guidelines, and an FDA Drug TabletNovember 17th, 2017
  • Join now to see all

Professional Memberships